Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT04482660

Characterization of Cerebral Tau Aggregates With 18F-RO6958948 PET in the ALFA Population

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation · Academic / Other
Sex
All
Age
45 Years
Healthy volunteers
Accepted

Summary

This study will characterize tau tracer retention by Positron Emission Tomography (PET) as a function of amyloid levels transversally and longitudinally.

Detailed description

CROSS-SECTIONAL OBJECTIVES * To measure 18F-RO6958948 retention in selected participants of ALFA-related studies as a function of amyloid levels. * To study the relation between 18F-RO6958948 retention and amyloid levels. * To characterize imaging correlates as a function of tau and amyloid levels. * To study the role of tau retention on cognitive performance. * To define predictors of tau retention. LONGITUDINAL OBJECTIVES * To measure tau accumulation and spreading in participants of the ALFA-related studies of BBRC as a function of baseline amyloid levels. * To study the dynamic relation between tau spreading and amyloid levels longitudinally. * To define predictors of tau spreading.

Conditions

Interventions

TypeNameDescription
PROCEDUREPositron emission tomography with 18F-RO6958948tau PET ()

Timeline

Start date
2021-03-29
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2020-07-22
Last updated
2025-05-31

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04482660. Inclusion in this directory is not an endorsement.